Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 30, 2017

Primary Completion Date

January 19, 2020

Study Completion Date

January 19, 2020

Conditions
Acute Ischemic Stroke
Interventions
DRUG

DS1040b

DS-1040b in solution for intravenous infusion

DRUG

Placebo

Saline solution for intravenous infusion

Trial Locations (20)

036-8563

Hirosaki University Hospital, Hirosaki

273-8588

Funabashi Municipal Medical Center, Funabashi

802-8555

Kokura Memorial Hospital, Kitakyushu

372-0006

Mihara Memorial Hospital, Isesaki

060-8570

Nakamura Memorial Hospital, Sapporo

660-8511

Japan Organization of Occupational Health and Safety Kansai Rosai Hospital, Amagasaki

650-0046

Kobe City Medical Center General Hospital, Kobe

663-8501

Hyogo College of Medicine College Hospital, Nishinomiya

305-8576

University of Tsukuba Hospital, Tsukuba

020-0066

Iwate Prefectural Central Hospital, Morioka

250-0001

Seisho Hospital, Odawara

240-8555

Yokohama Municipal Citizen's Hospital, Yokohama

514-8507

Mie University Hospital, Tsu

565-8565

National Cerebral and Cardiovascular Center, Suita

350-1298

Saitama Medical University International Medical Center, Hidaka

755-8505

Yamaguchi University Hospital, Ube

730-8518

Hiroshima City Hiroshima Citizens Hospital, Hiroshima

852-8521

Nagasaki University Hospital, Nagasaki

950-1197

Niigata City General Hospital, Niigata

641-8509

Wakayama Medical University Hospital, Wakayama

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT03198715 - Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy | Biotech Hunter | Biotech Hunter